The clinical utility of integrative genomics in childhood cancer extends beyond targetable mutations
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The clinical utility of integrative genomics in childhood cancer extends beyond targetable mutations
Authors
Keywords
-
Journal
Nature Cancer
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-12-31
DOI
10.1038/s43018-022-00474-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Actionable Tumor Alterations and Treatment Protocol Enrollment of Pediatric and Young Adult Patients With Refractory Cancers in the National Cancer Institute–Children's Oncology Group Pediatric MATCH Trial
- (2022) D. Williams Parsons et al. JOURNAL OF CLINICAL ONCOLOGY
- Feasibility of whole genome and transcriptome profiling in pediatric and young adult cancers
- (2022) N. Shukla et al. Nature Communications
- Comprehensive germline-genomic and clinical profiling in 160 unselected children and adolescents with cancer
- (2021) Rabea Wagener et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- Pilot study of nivolumab in pediatric patients with hypermutant cancers.
- (2021) Daniel A. Morgenstern et al. JOURNAL OF CLINICAL ONCOLOGY
- Genomes for Kids: The scope of pathogenic mutations in pediatric cancer revealed by comprehensive DNA and RNA sequencing
- (2021) Scott Newman et al. Cancer Discovery
- The pediatric precision oncology INFORM registry: clinical outcome and benefit for patients with very high-evidence targets
- (2021) Cornelis M. van Tilburg et al. Cancer Discovery
- Genomic and Transcriptomic Analysis of Relapsed and Refractory Childhood Solid Tumors Reveals a Diverse Molecular Landscape and Mechanisms of Immune Evasion
- (2021) Sara A. Byron et al. CANCER RESEARCH
- The repertoire of mutational signatures in human cancer
- (2020) Ludmil B. Alexandrov et al. NATURE
- Comprehensive germline genomic profiles of children, adolescents and young adults with solid tumors
- (2020) Sara Akhavanfard et al. Nature Communications
- Frequency of Pathogenic Germline Variants in Cancer-Susceptibility Genes in Patients With Osteosarcoma
- (2020) Lisa Mirabello et al. JAMA Oncology
- Whole genome, transcriptome and methylome profiling enhances actionable target discovery in high-risk pediatric cancer
- (2020) Marie Wong et al. NATURE MEDICINE
- Pan-neuroblastoma analysis reveals age- and signature-associated driver alterations
- (2020) Samuel W. Brady et al. Nature Communications
- PyClone-VI: scalable inference of clonal population structures using whole genome data
- (2020) Sierra Gillis et al. BMC BIOINFORMATICS
- Germline Cancer-Predisposition Variants in Pediatric Rhabdomyosarcoma: A Report from the Children’s Oncology Group
- (2020) He Li et al. JNCI-Journal of the National Cancer Institute
- Nationwide germline whole genome sequencing of 198 consecutive pediatric cancer patients reveals a high incidence of cancer prone syndromes
- (2020) Anna Byrjalsen et al. PLoS Genetics
- Tumor mutational load predicts survival after immunotherapy across multiple cancer types
- (2019) Robert M. Samstein et al. NATURE GENETICS
- Therapeutic implications of germline genetic findings in cancer
- (2019) Subotheni Thavaneswaran et al. Nature Reviews Clinical Oncology
- Childhood cerebellar tumours mirror conserved fetal transcriptional programs
- (2019) Maria C. Vladoiu et al. NATURE
- Immunogenic neoantigens derived from gene fusions stimulate T cell responses
- (2019) Wei Yang et al. NATURE MEDICINE
- Tumour lineage shapes BRCA-mediated phenotypes
- (2019) Philip Jonsson et al. NATURE
- A tailored molecular profiling programme for children with cancer to identify clinically actionable genetic alterations
- (2019) Sally L. George et al. EUROPEAN JOURNAL OF CANCER
- Estimated number of adult survivors of childhood cancer in United States with cancer‐predisposing germline variants
- (2019) Carmen L. Wilson et al. PEDIATRIC BLOOD & CANCER
- Genomic Profiling of Childhood Tumor Patient-Derived Xenograft Models to Enable Rational Clinical Trial Design
- (2019) Jo Lynne Rokita et al. Cell Reports
- Inactivation of CDK12 Delineates a Distinct Immunogenic Class of Advanced Prostate Cancer
- (2018) Yi-Mi Wu et al. CELL
- Spectrum and prevalence of genetic predisposition in medulloblastoma: a retrospective genetic study and prospective validation in a clinical trial cohort
- (2018) Sebastian M Waszak et al. LANCET ONCOLOGY
- The landscape of genomic alterations across childhood cancers
- (2018) Susanne N. Gröbner et al. NATURE
- Neoadjuvant PD-1 Blockade in Resectable Lung Cancer
- (2018) Patrick M. Forde et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pan-cancer genome and transcriptome analyses of 1,699 paediatric leukaemias and solid tumours
- (2018) Xiaotu Ma et al. NATURE
- Single-cell transcriptomes from human kidneys reveal the cellular identity of renal tumors
- (2018) Matthew D. Young et al. SCIENCE
- Rearrangement bursts generate canonical gene fusions in bone and soft tissue tumors
- (2018) Nathaniel D. Anderson et al. SCIENCE
- Clinical cancer genomic profiling by three-platform sequencing of whole genome, whole exome and transcriptome
- (2018) Michael Rusch et al. Nature Communications
- Integrating somatic variant data and biomarkers for germline variant classification in cancer predisposition genes
- (2018) Michael F. Walsh et al. HUMAN MUTATION
- Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer
- (2017) Marilyn M. Li et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- HRDetect is a predictor of BRCA1 and BRCA2 deficiency based on mutational signatures
- (2017) Helen Davies et al. NATURE MEDICINE
- NGSCheckMate: software for validating sample identity in next-generation sequencing studies within and across data types
- (2017) Sejoon Lee et al. NUCLEIC ACIDS RESEARCH
- Reconstructing metastatic seeding patterns of human cancers
- (2017) Johannes G. Reiter et al. Nature Communications
- Precision Medicine in Children and Young Adults with Hematologic Malignancies and Blood Disorders: The Columbia University Experience
- (2017) Lianna J. Marks et al. Frontiers in Pediatrics
- MultiDimensional ClinOmics for Precision Therapy of Children and Adolescent Young Adults with Relapsed and Refractory Cancer: A Report from the Center for Cancer Research
- (2016) W. Chang et al. CLINICAL CANCER RESEARCH
- Next-generation personalised medicine for high-risk paediatric cancer patients – The INFORM pilot study
- (2016) Barbara C. Worst et al. EUROPEAN JOURNAL OF CANCER
- Immune Checkpoint Inhibition for Hypermutant Glioblastoma Multiforme Resulting From Germline Biallelic Mismatch Repair Deficiency
- (2016) Eric Bouffet et al. JOURNAL OF CLINICAL ONCOLOGY
- Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: 11 year follow-up of a prospective observational study
- (2016) Anita Villani et al. LANCET ONCOLOGY
- Divergent clonal selection dominates medulloblastoma at recurrence
- (2016) A. Sorana Morrissy et al. NATURE
- CNVkit: Genome-Wide Copy Number Detection and Visualization from Targeted DNA Sequencing
- (2016) Eric Talevich et al. PLoS Computational Biology
- Diagnostic Yield of Clinical Tumor and Germline Whole-Exome Sequencing for Children With Solid Tumors
- (2016) D. Williams Parsons et al. JAMA Oncology
- Multicenter Feasibility Study of Tumor Molecular Profiling to Inform Therapeutic Decisions in Advanced Pediatric Solid Tumors
- (2016) Marian H. Harris et al. JAMA Oncology
- Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology
- (2015) Sue Richards et al. GENETICS IN MEDICINE
- Integrative Clinical Sequencing in the Management of Refractory or Relapsed Cancer in Youth
- (2015) Rajen J. Mody et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Mutations driving CLL and their evolution in progression and relapse
- (2015) Dan A. Landau et al. NATURE
- Relapsed neuroblastomas show frequent RAS-MAPK pathway mutations
- (2015) Thomas F Eleveld et al. NATURE GENETICS
- Mutational dynamics between primary and relapse neuroblastomas
- (2015) Alexander Schramm et al. NATURE GENETICS
- Germline Mutations in Predisposition Genes in Pediatric Cancer
- (2015) Jinghui Zhang et al. NEW ENGLAND JOURNAL OF MEDICINE
- Exome sequencing of osteosarcoma reveals mutation signatures reminiscent of BRCA deficiency
- (2015) Michal Kovac et al. Nature Communications
- Emergence of New ALK Mutations at Relapse of Neuroblastoma
- (2014) Gudrun Schleiermacher et al. JOURNAL OF CLINICAL ONCOLOGY
- The Genomic Landscape of Pediatric Ewing Sarcoma
- (2014) B. D. Crompton et al. Cancer Discovery
- Mutational Analysis Reveals the Origin and Therapy-Driven Evolution of Recurrent Glioma
- (2013) B. E. Johnson et al. SCIENCE
- GapFiller: a de novo assembly approach to fill the gap within paired reads
- (2012) Francesca Nadalin et al. BMC BIOINFORMATICS
- Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: a prospective observational study
- (2011) Anita Villani et al. LANCET ONCOLOGY
- Higher occurrence of childhood cancer in families with germline mutations in BRCA2, MMR and CDKN2A genes
- (2008) Susanne Magnusson et al. Familial Cancer
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More